Combining LSD1 and JAK-STAT inhibition targets Down syndrome-associated myeloid leukemia at its core
Juliane Grimm(Martin Luther University Halle-Wittenberg), Jan‐Henning Klusmann(Goethe University Frankfurt)
Cited by 0
Related Papers
miR-125b-2 is a potential oncomiR on human chromosome 21 in megakaryoblastic leukemia
|Genes & Development|2010|218
The non-coding RNA landscape of human hematopoiesis and leukemia
|Nature Communications|2017|164
CRISPR/Cas9 editing of NKG2A improves the efficacy of primary CD33-directed chimeric antigen receptor natural killer cells
|Nature Communications|2024|71
Molecular Mechanisms of the Genetic Predisposition to Acute Megakaryoblastic Leukemia in Infants With Down Syndrome
|Frontiers in Oncology|2021|41